ROYAL BANK OF CANADA

Bank

Position in NRXP — NRX Pharmaceuticals, Inc.

CIK 1000275 TORONTO, A6

Position in NRXP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,180

+$2,836 QoQ

Shares Held

2,000

-20.3% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#39

of 47 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. NRXP ranks #297 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	6,182,479	$490,208,754
2	VRTX	Vertex Pharmaceuticals Inc / Ma	980,259	$486,924,048
3	ALNY	Alnylam Pharmaceuticals, Inc.	875,859	$263,659,830
4	INCY	Incyte Corp	1,132,050	$128,329,182
5	REGN	Regeneron Pharmaceuticals, Inc.	174,515	$108,817,078
6	MRNA	Moderna, Inc.	944,457	$66,140,319
7	INSM	INSMED Inc	416,487	$44,405,840
8	HALO	Halozyme Therapeutics, Inc.	545,761	$42,716,712

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,180	2,000	-20.3%	Shares	Defined	2026-08-14
2026-03-31	$5,344	2,509	+25.4%	Shares	Defined	2026-05-15
2025-12-31	$5,420	2,000	-50.2%	Shares	Defined	2026-02-17
2024-06-30	$9,791	4,013	+3110.4%	Shares	Defined	2024-11-06
2024-03-31	$59	125	-99.9%	Shares	Defined	2024-11-05
2023-12-31	$69,096	150,209	-11.9%	Shares	Defined	2024-02-14
2023-09-30	$44,308	170,419	-0.5%	Shares	Defined	2023-11-14
2023-06-30	$82,876	171,233	+135799.2%	Shares	Defined	2023-08-14
2023-03-31	$83	126	-1.6%	Shares	Defined	2023-05-15
2022-12-31	$142	128	-59.7%	Shares	Defined	2023-02-14
2022-09-30	$234	318	-39.2%	Shares	Defined	2022-11-14
2022-06-30	$313	523	-93.5%	Shares	Defined	2022-08-15
2021-06-30	$92,960	8,000	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.